{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:30:48Z","timestamp":1794893448134,"version":"4.9.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010608","name":"Universit\u00e0 degli Studi di Urbino Carlo Bo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010608","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Fungal infections represent a serious global health threat. The new emerging pathogens and the spread of different forms of resistance are now hardly challenging the tools available in therapy and diagnostics. With the commonly used diagnoses, fungal identification is often slow and inaccurate, and, on the other hand, some drugs currently used as treatments are significantly affected by the decrease in susceptibility. Herein, the antifungal arsenal is critically summarized. Besides describing the old approaches and their mechanisms, advantages, and limitations, the focus is dedicated to innovative strategies which are designed, identified, and developed to take advantage of the discrepancies between fungal and host cells. Relevant pathways and their role in survival and virulence are discussed as their suitability as sources of antifungal targets. In a similar way, molecules with antifungal activity are reported as potential agents\/precursors of the next generation of antimycotics. Particular attention was devoted to biotechnological entities, to their novelty and reliability, to drug repurposing and restoration, and to combinatorial applications yielding significant improvements in efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key points<\/jats:title>\n            <jats:p>\n              <jats:italic>\u2022 New antifungal agents and targets are needed to limit fungal morbidity and mortality.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:italic>\u2022 Therapeutics and diagnostics suffer of delays in innovation and lack of targets.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\n              <jats:italic>\u2022 Biologics, drug repurposing and combinations are the future of antifungal treatments.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00253-023-12884-8","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T08:02:23Z","timestamp":1705651343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Old and new strategies in therapy and diagnosis against fungal infections"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-1558","authenticated-orcid":false,"given":"Tania","family":"Vanzolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"12884_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1128\/AAC.00633-08","volume":"53","author":"PA Aeed","year":"2009","unstructured":"Aeed PA, Young CL, Nagiec MM, Elhammer AP (2009) Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. Antimicrob Agents Chemother 53:496\u2013504. https:\/\/doi.org\/10.1128\/AAC.00633-08","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","volume":"13","author":"D Allen","year":"2015","unstructured":"Allen D, Wilson D, Drew R, Perfect J (2015) Azole antifungals: 35 years of invasive fungal infection management. Expert Rev Anti Infect Ther 13:787\u2013798. https:\/\/doi.org\/10.1586\/14787210.2015.1032939","journal-title":"Expert Rev Anti Infect Ther"},{"key":"12884_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijmm.2017.07.011","volume":"307","author":"N Amarsaikhan","year":"2017","unstructured":"Amarsaikhan N, Albrecht-Eckardt D, Sasse C, Braus GH, Ogel ZB, Kniemeyer O (2017) Proteomic profiling of the antifungal drug response of Aspergillus fumigatus to voriconazole. Int J Med Microbiol IJMM 307:398\u2013408. https:\/\/doi.org\/10.1016\/j.ijmm.2017.07.011","journal-title":"Int J Med Microbiol IJMM"},{"key":"12884_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejmech.2019.05.031","volume":"176","author":"M Antoszczak","year":"2019","unstructured":"Antoszczak M, Huczy\u0144ski A (2019) Salinomycin and its derivatives \u2013 a new class of multiple-targeted \u201cmagic bullets\u201d. Eur J Med Chem 176:208\u2013227. https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.031","journal-title":"Eur J Med Chem"},{"key":"12884_CR5","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.3390\/molecules27207034","volume":"27","author":"P Aris","year":"2022","unstructured":"Aris P, Wei Y, Mohamadzadeh M, Xia X (2022) Griseofulvin: an updated overview of old and current knowledge. Mol Basel Switz 27:7034. https:\/\/doi.org\/10.3390\/molecules27207034","journal-title":"Mol Basel Switz"},{"key":"12884_CR6","doi-asserted-by":"publisher","first-page":"e02593-20","DOI":"10.1128\/AAC.02593-20","volume":"65","author":"JJ Artunduaga Bonilla","year":"2021","unstructured":"Artunduaga Bonilla JJ, Honorato L, Haranahalli K, Dib Ferreira Gremi\u00e3o I, Pereira SA, Guimar\u00e3es A, de Souza Baptista AR, de Melo Tavares P, Rodrigues ML, Miranda K, Ojima I (2021) Antifungal activity of acylhydrazone derivatives against Sporothrix spp. Antimicrob Agents Chemother 65:e02593-20, AAC.02593-20. https:\/\/doi.org\/10.1128\/AAC.02593-20","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR7","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.2174\/092986712802430063","volume":"19","author":"R Aslam","year":"2012","unstructured":"Aslam R, Atindehou M, Lavaux T, Ha\u00efkel Y, Schneider F, Metz-Boutigue M-H (2012) Chromogranin A-derived peptides are involved in innate immunity. Curr Med Chem 19:4115\u20134123. https:\/\/doi.org\/10.2174\/092986712802430063","journal-title":"Curr Med Chem"},{"key":"12884_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fcimb.2019.00414","volume":"9","author":"RW Bastos","year":"2019","unstructured":"Bastos RW, Rossato L, Valero C, Lagrou K, Colombo AL, Goldman GH (2019) Potential of gallium as an antifungal agent. Front Cell Infect Microbiol 9:414. https:\/\/doi.org\/10.3389\/fcimb.2019.00414","journal-title":"Front Cell Infect Microbiol"},{"key":"12884_CR9","doi-asserted-by":"publisher","first-page":"e00831-16","DOI":"10.1128\/mBio.00831-16","volume":"7","author":"I Bauer","year":"2016","unstructured":"Bauer I, Varadarajan D, Pidroni A, Gross S, Vergeiner S, Faber B, Hermann M, Tribus M, Brosch G, Graessle S (2016) A class 1 histone deacetylase with potential as an antifungal target. mBio 7:e00831-16. https:\/\/doi.org\/10.1128\/mBio.00831-16","journal-title":"mBio"},{"key":"12884_CR10","doi-asserted-by":"publisher","first-page":"e1008757","DOI":"10.1371\/journal.ppat.1008757","volume":"16","author":"P Brandt","year":"2020","unstructured":"Brandt P, Garbe E, Vylkova S (2020) Catch the wave: metabolomic analyses in human pathogenic fungi. PLOS Pathog 16:e1008757. https:\/\/doi.org\/10.1371\/journal.ppat.1008757","journal-title":"PLOS Pathog"},{"key":"12884_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-1-59745-180-2_27","volume-title":"Antimicrobial drug resistance: mechanisms of drug resistance","author":"J Chandra","year":"2009","unstructured":"Chandra J, Mohammad S, Ghannoum MA (2009) Flucytosine: site of action, mechanism of resistance and use in combination therapy. In: Mayers DL (ed) Antimicrobial drug resistance: mechanisms of drug resistance. Humana Press, Totowa, NJ, pp 313\u2013326"},{"key":"12884_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mib.2014.05.001","volume":"20","author":"L Chatre","year":"2014","unstructured":"Chatre L, Ricchetti M (2014) Are mitochondria the Achilles\u2019 heel of the kingdom fungi? Curr Opin Microbiol 20:49\u201354. https:\/\/doi.org\/10.1016\/j.mib.2014.05.001","journal-title":"Curr Opin Microbiol"},{"key":"12884_CR13","doi-asserted-by":"publisher","first-page":"e95951","DOI":"10.1371\/journal.pone.0095951","volume":"9","author":"H-L Cheah","year":"2014","unstructured":"Cheah H-L, Lim V, Sandai D (2014) Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents. PloS One 9:e95951. https:\/\/doi.org\/10.1371\/journal.pone.0095951","journal-title":"PloS One"},{"key":"12884_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fmicb.2020.00296","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang Z, Chen Z, Li Y, Su S, Sun S (2020) Potential antifungal targets based on glucose metabolism pathways of Candida albicans. Front Microbiol 11:296. https:\/\/doi.org\/10.3389\/fmicb.2020.00296","journal-title":"Front Microbiol"},{"key":"12884_CR15","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1093\/ofid\/ofx163.031","volume":"4","author":"K Cook","year":"2017","unstructured":"Cook K, Sraubol T, Campbell KB, Mourad A, Stiber J, Perfect JR, Johnson M (2017) QTc Prolongation in patients receiving triazoles and amiodarone. Open Forum Infect Dis 4:S84. https:\/\/doi.org\/10.1093\/ofid\/ofx163.031","journal-title":"Open Forum Infect Dis"},{"key":"12884_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fmicb.2017.01059","volume":"8","author":"B De Coninck","year":"2017","unstructured":"De Coninck B, Verheesen P, Vos CM, Van Daele I, De Bolle MF, Vieira JV, Peferoen M, Cammue BPA, Thevissen K (2017) Fungal glucosylceramide-specific camelid single domain antibodies are characterized by broad spectrum antifungal activity. Front Microbiol 8:1059. https:\/\/doi.org\/10.3389\/fmicb.2017.01059","journal-title":"Front Microbiol"},{"key":"12884_CR17","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.bbamem.2006.08.017","volume":"1758","author":"A Delgado","year":"2006","unstructured":"Delgado A, Casas J, Llebaria A, Abad JL, Fabrias G (2006) Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta BBA - Biomembr 1758:1957\u20131977. https:\/\/doi.org\/10.1016\/j.bbamem.2006.08.017","journal-title":"Biochim Biophys Acta BBA - Biomembr"},{"key":"12884_CR18","doi-asserted-by":"publisher","unstructured":"Deprez M-A, Eskes E, Winderickx J, Wilms T (2018) The TORC1-Sch9 pathway as a crucial mediator of chronological lifespan in the yeast Saccharomyces cerevisiae. FEMS Yeast Res 18. https:\/\/doi.org\/10.1093\/femsyr\/foy048","DOI":"10.1093\/femsyr\/foy048"},{"key":"12884_CR19","doi-asserted-by":"publisher","first-page":"e0276786","DOI":"10.1371\/journal.pone.0276786","volume":"17","author":"T Di Mambro","year":"2022","unstructured":"Di Mambro T, Vanzolini T, Bianchi M, Crinelli R, Canonico B, Tasini F, Menotta M, Magnani M (2022) Development and in vitro characterization of a humanized scFv against fungal infections. PloS One 17:e0276786. https:\/\/doi.org\/10.1371\/journal.pone.0276786","journal-title":"PloS One"},{"key":"12884_CR20","doi-asserted-by":"publisher","first-page":"19500","DOI":"10.1038\/s41598-021-98659-5","volume":"11","author":"T Di Mambro","year":"2021","unstructured":"Di Mambro T, Vanzolini T, Bruscolini P, Perez-Gaviro S, Marra E, Roscilli G, Bianchi M, Fraternale A, Schiavano GF, Canonico B, Magnani M (2021) A new humanized antibody is effective against pathogenic fungi in vitro. Sci Rep 11:19500. https:\/\/doi.org\/10.1038\/s41598-021-98659-5","journal-title":"Sci Rep"},{"key":"12884_CR21","doi-asserted-by":"publisher","unstructured":"e Silva KS, Silva L, Gon\u00e7ales R, Neves B, Soares C, Pereira M (2020) Setting new routes for antifungal drug discovery against pathogenic fungi. Curr Pharm Des 26. https:\/\/doi.org\/10.2174\/1381612826666200317125956","DOI":"10.2174\/1381612826666200317125956"},{"key":"12884_CR22","doi-asserted-by":"publisher","first-page":"e00642-18","DOI":"10.1128\/mBio.00642-18","volume":"9","author":"CM Fernandes","year":"2018","unstructured":"Fernandes CM, Goldman GH, Del Poeta M (2018) Biological roles played by sphingolipids in dimorphic and filamentous fungi. mBio 9:e00642-18. https:\/\/doi.org\/10.1128\/mBio.00642-18","journal-title":"mBio"},{"key":"12884_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.fgb.2003.10.004","volume":"41","author":"JR Fortwendel","year":"2004","unstructured":"Fortwendel JR, Panepinto JC, Seitz AE, Askew DS, Rhodes JC (2004) Aspergillus fumigatus rasA and rasB regulate the timing and morphology of asexual development. Fungal Genet Biol 41:129\u2013139. https:\/\/doi.org\/10.1016\/j.fgb.2003.10.004","journal-title":"Fungal Genet Biol"},{"key":"12884_CR24","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2741\/4050","volume":"17","author":"M Gorska","year":"2012","unstructured":"Gorska M (2012) Geldanamycin and its derivatives as Hsp90 inhibitors. Front Biosci 17:2269. https:\/\/doi.org\/10.2741\/4050","journal-title":"Front Biosci"},{"key":"12884_CR25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/myc.12955","volume":"62","author":"TP Hai","year":"2019","unstructured":"Hai TP, Van AD, Ngan NTT, Nhat LTH, Lan NPH, Vinh Chau NV, Thwaites GE, Krysan D, Day JN (2019) The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans. Mycoses 62:818\u2013825. https:\/\/doi.org\/10.1111\/myc.12955","journal-title":"Mycoses"},{"key":"12884_CR26","doi-asserted-by":"publisher","first-page":"35149","DOI":"10.1074\/jbc.M111.250506","volume":"286","author":"MA Hast","year":"2011","unstructured":"Hast MA, Nichols CB, Armstrong SM, Kelly SM, Hellinga HW, Alspaugh JA, Beese LS (2011) Structures of Cryptococcus neoformans protein farnesyltransferase reveal strategies for developing inhibitors that target fungal pathogens. J Biol Chem 286:35149\u201335162. https:\/\/doi.org\/10.1074\/jbc.M111.250506","journal-title":"J Biol Chem"},{"key":"12884_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2217\/fmb.09.106","volume":"4","author":"DA Hogan","year":"2009","unstructured":"Hogan DA, Sundstrom P (2009) The Ras\/cAMP\/PKA signaling pathway and virulence in Candida albicans. Future Microbiol 4:1263\u20131270. https:\/\/doi.org\/10.2217\/fmb.09.106","journal-title":"Future Microbiol"},{"key":"12884_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/metabo10030106","volume":"10","author":"J Hou\u0161\u0165","year":"2020","unstructured":"Hou\u0161\u0165 J, Sp\u00ed\u017eek J, Havl\u00ed\u010dek V (2020) Antifungal drugs. Metabolites 10:106. https:\/\/doi.org\/10.3390\/metabo10030106","journal-title":"Metabolites"},{"key":"12884_CR29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/pharmaceutics15051550","volume":"15","author":"S Jati","year":"2023","unstructured":"Jati S, Mahata S, Das S, Chatterjee S, Mahata SK (2023) Catestatin: antimicrobial functions and potential therapeutics. Pharmaceutics 15:1550. https:\/\/doi.org\/10.3390\/pharmaceutics15051550","journal-title":"Pharmaceutics"},{"key":"12884_CR30","doi-asserted-by":"publisher","first-page":"936814","DOI":"10.3389\/fcimb.2022.936814","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang H, Xiong J, Tan L, Jin P, Sun Y, Yang L, Tan J (2022) In vitro interactions of antifungal agents and everolimus against Aspergillus species. Front Cell Infect Microbiol 12:936814. https:\/\/doi.org\/10.3389\/fcimb.2022.936814","journal-title":"Front Cell Infect Microbiol"},{"key":"12884_CR31","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1038\/s41467-019-12199-1","volume":"10","author":"PR Juvvadi","year":"2019","unstructured":"Juvvadi PR, Fox D, Bobay BG, Hoy MJ, Gobeil SMC, Venters RA, Chang Z, Lin JJ, Averette AF, Cole DC, Barrington BC, Wheaton JD, Ciofani M, Trzoss M, Li X, Lee SC, Chen Y-L, Mutz M, Spicer LD et al (2019) Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents. Nat Commun 10:4275. https:\/\/doi.org\/10.1038\/s41467-019-12199-1","journal-title":"Nat Commun"},{"key":"12884_CR32","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1345\/aph.1M218","volume":"43","author":"R Karwa","year":"2009","unstructured":"Karwa R, Wargo KA (2009) Efungumab: a novel agent in the treatment of invasive candidiasis. Ann Pharmacother 43:1818\u20131823. https:\/\/doi.org\/10.1345\/aph.1M218","journal-title":"Ann Pharmacother"},{"key":"12884_CR33","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jiac.2021.06.017","volume":"27","author":"H Kato","year":"2021","unstructured":"Kato H, Hagihara M, Shibata Y, Asai N, Yamagishi Y, Iwamoto T, Mikamo H (2021) Comparison of mortality between echinocandins and polyenes for an initial treatment of candidemia: a systematic review and meta-analysis. J Infect Chemother Off J Jpn Soc Chemother 27:1562\u20131570. https:\/\/doi.org\/10.1016\/j.jiac.2021.06.017","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"key":"12884_CR34","doi-asserted-by":"publisher","first-page":"a019299","DOI":"10.1101\/cshperspect.a019299","volume":"4","author":"TR Kozel","year":"2014","unstructured":"Kozel TR, Wickes B (2014) Fungal diagnostics. Cold Spring Harb Perspect Med 4:a019299. https:\/\/doi.org\/10.1101\/cshperspect.a019299","journal-title":"Cold Spring Harb Perspect Med"},{"key":"12884_CR35","doi-asserted-by":"publisher","first-page":"e1001069","DOI":"10.1371\/journal.ppat.1001069","volume":"6","author":"SL LaFayette","year":"2010","unstructured":"LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, Gunatilaka AAL, Perfect JR, Cowen LE (2010) PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, Calcineurin, and Hsp90. PLOS Pathog 6:e1001069. https:\/\/doi.org\/10.1371\/journal.ppat.1001069","journal-title":"PLOS Pathog"},{"key":"12884_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1128\/EC.00032-12","volume":"11","author":"F Lamoth","year":"2012","unstructured":"Lamoth F, Juvvadi PR, Fortwendel JR, Steinbach WJ (2012) Heat shock protein 90 is required for conidiation and cell wall integrity in Aspergillus fumigatus. Eukaryot Cell 11:1324\u20131332. https:\/\/doi.org\/10.1128\/EC.00032-12","journal-title":"Eukaryot Cell"},{"key":"12884_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1128\/AAC.01857-12","volume":"57","author":"F Lamoth","year":"2013","unstructured":"Lamoth F, Juvvadi PR, Gehrke C, Steinbach WJ (2013) In vitro activity of calcineurin and heat shock protein 90 inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. Antimicrob Agents Chemother 57:1035\u20131039. https:\/\/doi.org\/10.1128\/AAC.01857-12","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","volume":"26","author":"R Laniado-Labor\u00edn","year":"2009","unstructured":"Laniado-Labor\u00edn R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26:223\u2013227. https:\/\/doi.org\/10.1016\/j.riam.2009.06.003","journal-title":"Rev Iberoam Micol"},{"key":"12884_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/jof6040261","volume":"6","author":"DJ Larwood","year":"2020","unstructured":"Larwood DJ (2020) Nikkomycin Z-ready to meet the promise? J Fungi Basel Switz 6:261. https:\/\/doi.org\/10.3390\/jof6040261","journal-title":"J Fungi Basel Switz"},{"key":"12884_CR40","doi-asserted-by":"publisher","first-page":"825745","DOI":"10.3389\/fmicb.2022.825745","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Zhang X, Kayastha S, Tan L, Zhang H, Tan J, Li L, Mao J, Sun Y (2022) A preliminary in vitro and in vivo evaluation of the effect and action mechanism of 17-AAG combined with azoles against azole-resistant Candida spp. Front Microbiol 13:825745. https:\/\/doi.org\/10.3389\/fmicb.2022.825745","journal-title":"Front Microbiol"},{"key":"12884_CR41","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1021\/acscentsci.0c01222","volume":"6","author":"BS Loh","year":"2020","unstructured":"Loh BS, Ang WH (2020) \u201cIlluminating\u201d echinocandins mechanism of action. ACS Cent Sci 6:1651\u20131653. https:\/\/doi.org\/10.1021\/acscentsci.0c01222","journal-title":"ACS Cent Sci"},{"key":"12884_CR42","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/AAC.42.11.3018","volume":"42","author":"EK Manavathu","year":"1998","unstructured":"Manavathu EK, Cutright JL, Chandrasekar PH (1998) Organism-dependent fungicidal activities of azoles. Antimicrob Agents Chemother 42:3018\u20133021","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/10408347.2020.1811947","volume":"52","author":"GD Marena","year":"2022","unstructured":"Marena GD, Ramos MADS, Bauab TM, Chorilli M (2022) A critical review of analytical methods for quantification of amphotericin B in biological samples and pharmaceutical formulations. Crit Rev Anal Chem 52:555\u2013576. https:\/\/doi.org\/10.1080\/10408347.2020.1811947","journal-title":"Crit Rev Anal Chem"},{"key":"12884_CR44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/mol.113.085902","volume":"84","author":"N Mast","year":"2013","unstructured":"Mast N, Zheng W, Stout CD, Pikuleva IA (2013) Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1. Mol Pharmacol 84:86\u201394. https:\/\/doi.org\/10.1124\/mol.113.085902","journal-title":"Mol Pharmacol"},{"key":"12884_CR45","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1073\/pnas.1116510109","volume":"109","author":"T Maurer","year":"2012","unstructured":"Maurer T, Garrenton LS, Oh A, Pitts K, Anderson DJ, Skelton NJ, Fauber BP, Pan B, Malek S, Stokoe D, Ludlam MJC, Bowman KK, Wu J, Giannetti AM, Starovasnik MA, Mellman I, Jackson PK, Rudolph J, Wang W, Fang G (2012) Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity. Proc Natl Acad Sci USA 109:5299\u20135304. https:\/\/doi.org\/10.1073\/pnas.1116510109","journal-title":"Proc Natl Acad Sci USA"},{"key":"12884_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1574-6968.2002.tb11283.x","volume":"213","author":"P McGeady","year":"2002","unstructured":"McGeady P, Logan DA, Wansley DL (2002) A protein-farnesyl transferase inhibitor interferes with the serum-induced conversion of Candida albicans from a cellular yeast form to a filamentous form. FEMS Microbiol Lett 213:41\u201344. https:\/\/doi.org\/10.1111\/j.1574-6968.2002.tb11283.x","journal-title":"FEMS Microbiol Lett"},{"key":"12884_CR47","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.18632\/oncotarget.2077","volume":"5","author":"SH Millson","year":"2014","unstructured":"Millson SH, Piper PW (2014) Insights from yeast into whether the rapamycin inhibition of heat shock transcription factor (Hsf1) can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor. Oncotarget 5:5054\u20135064","journal-title":"Oncotarget"},{"key":"12884_CR48","doi-asserted-by":"publisher","first-page":"e01719","DOI":"10.1128\/AAC.01719-20","volume":"65","author":"C Mota Fernandes","year":"2021","unstructured":"Mota Fernandes C, Dasilva D, Haranahalli K, McCarthy JB, Mallamo J, Ojima I, Del Poeta M (2021) The future of antifungal drug therapy: novel compounds and targets. Antimicrob Agents Chemother 65:e01719\u2013e01720. https:\/\/doi.org\/10.1128\/AAC.01719-20","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR49","doi-asserted-by":"publisher","first-page":"19982","DOI":"10.1074\/jbc.RA118.005314","volume":"293","author":"P Mrak","year":"2018","unstructured":"Mrak P, Krastel P, Pivk Lukan\u010di\u010d P, Tao J, Pistorius D, Moore CM (2018) Discovery of the actinoplanic acid pathway in Streptomyces rapamycinicus reveals a genetically conserved synergism with rapamycin. J Biol Chem 293:19982\u201319995. https:\/\/doi.org\/10.1074\/jbc.RA118.005314","journal-title":"J Biol Chem"},{"key":"12884_CR50","doi-asserted-by":"publisher","first-page":"e02689","DOI":"10.1128\/AAC.02689-18","volume":"63","author":"I Nakamura","year":"2019","unstructured":"Nakamura I, Ohsumi K, Takeda S, Katsumata K, Matsumoto S, Akamatsu S, Mitori H, Nakai T (2019) ASP2397 Is a novel natural compound that exhibits rapid and potent fungicidal activity against Aspergillus species through a specific transporter. Antimicrob Agents Chemother 63:e02689\u2013e02618. https:\/\/doi.org\/10.1128\/AAC.02689-18","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","volume":"30","author":"JE Nett","year":"2016","unstructured":"Nett JE, Andes DR (2016) Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin North Am 30:51\u201383. https:\/\/doi.org\/10.1016\/j.idc.2015.10.012","journal-title":"Infect Dis Clin North Am"},{"key":"12884_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3389\/fpls.2020.00371","volume":"11","author":"HTT Nguyen","year":"2020","unstructured":"Nguyen HTT, Choi S, Kim S, Lee J-H, Park AR, Yu NH, Yoon H, Bae C-H, Yeo JH, Choi GJ, Son H, Kim J-C (2020) The Hsp90 inhibitor, monorden, is a promising lead compound for the development of novel fungicides. Front Plant Sci 11:371. https:\/\/doi.org\/10.3389\/fpls.2020.00371","journal-title":"Front Plant Sci"},{"key":"12884_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-021-00294-8","volume":"6","author":"LVN Oliveira","year":"2021","unstructured":"Oliveira LVN, Wang R, Specht CA, Levitz SM (2021) Vaccines for human fungal diseases: close but still a long way to go. Npj Vaccines 6:1\u20138. https:\/\/doi.org\/10.1038\/s41541-021-00294-8","journal-title":"Npj Vaccines"},{"key":"12884_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/5584_2019_453","volume":"1282","author":"I Oltu","year":"2020","unstructured":"Oltu I, Cepoi L, Rudic V, Rudi L, Chiriac T, Valuta A, Codreanu S (2020a) Current research and new perspectives in antifungal drug development. Adv Exp Med Biol 1282:71\u201383. https:\/\/doi.org\/10.1007\/5584_2019_453","journal-title":"Adv Exp Med Biol"},{"key":"12884_CR55","first-page":"71","volume-title":"Advances in microbiology, infectious diseases and public health: Volume 14","author":"I Oltu","year":"2020","unstructured":"Oltu I, Cepoi L, Rudic V, Rudi L, Chiriac T, Valuta A, Codreanu S (2020b) Current research and new perspectives in antifungal drug development. In: Donelli G (ed) Advances in microbiology, infectious diseases and public health: Volume 14. Springer International Publishing, Cham, pp 71\u201383"},{"key":"12884_CR56","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/DDDT.S339349","volume":"17","author":"NA Phillips","year":"2023","unstructured":"Phillips NA, Rocktashel M, Merjanian L (2023) Ibrexafungerp for the treatment of vulvovaginal candidiasis: design, development and place in therapy. Drug Des Devel Ther 17:363\u2013367. https:\/\/doi.org\/10.2147\/DDDT.S339349","journal-title":"Drug Des Devel Ther"},{"key":"12884_CR57","doi-asserted-by":"publisher","first-page":"e94832","DOI":"10.1371\/journal.pone.0094832","volume":"9","author":"RSD Prado","year":"2014","unstructured":"Prado RSD, Alves RJ, Oliveira CMAD, Kato L, Silva RAD, Quintino GO, do Desterro Cunha S, de Almeida Soares CM, Pereira M (2014) Inhibition of Paracoccidioides lutzii Pb01 isocitrate lyase by the natural compound argentilactone and its semi-synthetic derivatives. PLOS ONE 9:e94832. https:\/\/doi.org\/10.1371\/journal.pone.0094832","journal-title":"PLOS ONE"},{"key":"12884_CR58","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/clinids\/22.2.336","volume":"22","author":"TJ Pursley","year":"1996","unstructured":"Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA (1996) Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis Off Publ Infect Dis Soc Am 22:336\u2013340. https:\/\/doi.org\/10.1093\/clinids\/22.2.336","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"12884_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1476-0711-12-37","volume":"12","author":"J Qiao","year":"2013","unstructured":"Qiao J, Gao P, Jiang X, Fang H (2013) In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida. Ann Clin Microbiol Antimicrob 12:37. https:\/\/doi.org\/10.1186\/1476-0711-12-37","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"12884_CR60","doi-asserted-by":"publisher","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","volume":"7","author":"AM Rauseo","year":"2020","unstructured":"Rauseo AM, Coler-Reilly A, Larson L, Spec A (2020) Hope on the horizon: novel fungal treatments in development. Open Forum. Infect Dis 7:ofaa016. https:\/\/doi.org\/10.1093\/ofid\/ofaa016","journal-title":"Infect Dis"},{"key":"12884_CR61","doi-asserted-by":"publisher","first-page":"e15572","DOI":"10.1371\/journal.pone.0015572","volume":"6","author":"R Rhome","year":"2011","unstructured":"Rhome R, Singh A, Kechichian T, Drago M, Morace G, Luberto C, Poeta MD (2011) Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal. PLOS ONE 6:e15572. https:\/\/doi.org\/10.1371\/journal.pone.0015572","journal-title":"PLOS ONE"},{"key":"12884_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1046\/j.1365-2958.2002.02926.x","volume":"44","author":"M Richard","year":"2002","unstructured":"Richard M, Ibata-Ombetta S, Dromer F, Bordon-Pallier F, Jouault T, Gaillardin C (2002) Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence and resistance to macrophages. Mol Microbiol 44:841\u2013853. https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02926.x","journal-title":"Mol Microbiol"},{"key":"12884_CR63","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI27890","volume":"116","author":"PC Rittershaus","year":"2006","unstructured":"Rittershaus PC, Kechichian TB, Allegood JC, Merrill AH, Hennig M, Luberto C, Poeta MD (2006) Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J Clin Invest 116:1651\u20131659. https:\/\/doi.org\/10.1172\/JCI27890","journal-title":"J Clin Invest"},{"key":"12884_CR64","doi-asserted-by":"publisher","first-page":"e0007964","DOI":"10.1371\/journal.pntd.0007964","volume":"14","author":"ML Rodrigues","year":"2020","unstructured":"Rodrigues ML, Nosanchuk JD (2020) Fungal diseases as neglected pathogens: a wake-up call to public health officials. PLoS Negl Trop Dis 14:e0007964. https:\/\/doi.org\/10.1371\/journal.pntd.0007964","journal-title":"PLoS Negl Trop Dis"},{"key":"12884_CR65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/82_2020_207","volume":"425","author":"M Samalova","year":"2020","unstructured":"Samalova M, Carr P, Bromley M, Blatzer M, Moya-Nilges M, Latg\u00e9 J-P, Mouyna I (2020) GPI Anchored proteins in Aspergillus fumigatus and cell wall morphogenesis. Curr Top Microbiol Immunol 425:167\u2013186. https:\/\/doi.org\/10.1007\/82_2020_207","journal-title":"Curr Top Microbiol Immunol"},{"key":"12884_CR66","doi-asserted-by":"publisher","first-page":"e0216085","DOI":"10.1371\/journal.pone.0216085","volume":"14","author":"G Sass","year":"2019","unstructured":"Sass G, Ansari SR, Dietl A-M, D\u00e9ziel E, Haas H, Stevens DA (2019) Intermicrobial interaction: Aspergillus fumigatus siderophores protect against competition by Pseudomonas aeruginosa. PLOS ONE 14:e0216085. https:\/\/doi.org\/10.1371\/journal.pone.0216085","journal-title":"PLOS ONE"},{"key":"12884_CR67","doi-asserted-by":"publisher","unstructured":"\u015een Kaya S, Kiraz N, Bari\u015f A, Turan D, \u00d6z Y, Da\u011f \u0130, Ayg\u00fcn G (2021) Effects of calcineurin inhibitors, cyclosporine A and tacrolimus (FK506), on the activity of antifungal drugs against Candida spp. J Med Microbiol 70. https:\/\/doi.org\/10.1099\/jmm.0.001354","DOI":"10.1099\/jmm.0.001354"},{"key":"12884_CR68","doi-asserted-by":"publisher","first-page":"foaa045","DOI":"10.1093\/femsyr\/foaa045","volume":"20","author":"G Shahi","year":"2020","unstructured":"Shahi G, Kumar M, Kumari S, Rudramurthy SM, Chakrabarti A, Gaur NA, Singh A, Prasad R (2020) A detailed lipidomic study of human pathogenic fungi Candida auris. FEMS Yeast Res 20:foaa045. https:\/\/doi.org\/10.1093\/femsyr\/foaa045","journal-title":"FEMS Yeast Res"},{"key":"12884_CR69","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cub.2012.01.062","volume":"22","author":"RS Shapiro","year":"2012","unstructured":"Shapiro RS, Sellam A, Tebbji F, Whiteway M, Nantel A, Cowen LE (2012) Pho85, Pcl1, and Hms1 Signaling governs Candida albicans morphogenesis induced by high temperature or Hsp90 compromise. Curr Biol 22:461\u2013470. https:\/\/doi.org\/10.1016\/j.cub.2012.01.062","journal-title":"Curr Biol"},{"key":"12884_CR70","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1128\/AAC.05954-11","volume":"56","author":"T Shibata","year":"2012","unstructured":"Shibata T, Takahashi T, Yamada E, Kimura A, Nishikawa H, Hayakawa H, Nomura N, Mitsuyama J (2012) T-2307 causes collapse of mitochondrial membrane potential in yeast. Antimicrob Agents Chemother 56:5892\u20135897. https:\/\/doi.org\/10.1128\/AAC.05954-11","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR71","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/jac\/dkaa562","volume":"76","author":"A Singh","year":"2021","unstructured":"Singh A, Singh P, Meis JF, Chowdhary A (2021) In vitro activity of the novel antifungal olorofim against dermatophytes and opportunistic moulds including Penicillium and Talaromyces species. J Antimicrob Chemother 76:1229\u20131233. https:\/\/doi.org\/10.1093\/jac\/dkaa562","journal-title":"J Antimicrob Chemother"},{"key":"12884_CR72","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1021\/ml300173e","volume":"3","author":"SB Singh","year":"2012","unstructured":"Singh SB, Liu W, Li X, Chen T, Shafiee A, Card D, Abruzzo G, Flattery A, Gill C, Thompson JR, Rosenbach M, Dreikorn S, Hornak V, Meinz M, Kurtz M, Kelly R, Onishi JC (2012) Antifungal spectrum, in vivo efficacy, and structure\u2013activity relationship of ilicicolin H. ACS Med Chem Lett 3:814\u2013817. https:\/\/doi.org\/10.1021\/ml300173e","journal-title":"ACS Med Chem Lett"},{"key":"12884_CR73","doi-asserted-by":"publisher","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","volume":"5","author":"SD Singh","year":"2009","unstructured":"Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE (2009) Hsp90 Governs echinocandin resistance in the pathogenic yeast Candida albicans via Calcineurin. PLOS Pathog 5:e1000532. https:\/\/doi.org\/10.1371\/journal.ppat.1000532","journal-title":"PLOS Pathog"},{"key":"12884_CR74","doi-asserted-by":"publisher","first-page":"105016","DOI":"10.1016\/j.micinf.2022.105016","volume":"24","author":"E Snelders","year":"2022","unstructured":"Snelders E, Moyrand F, Sturny-Lecl\u00e8re A, Vernel-Pauillac F, Volant S, Janbon G, Alanio A (2022) The role of glycosylphosphatidylinositol (gpi) anchored proteins in Cryptococcus neoformans. Microbes Infect 24:105016. https:\/\/doi.org\/10.1016\/j.micinf.2022.105016","journal-title":"Microbes Infect"},{"key":"12884_CR75","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2165\/11538110-000000000-00000","volume":"70","author":"A Subissi","year":"2010","unstructured":"Subissi A, Monti D, Togni G, Mailland F (2010) Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs 70:2133\u20132152. https:\/\/doi.org\/10.2165\/11538110-000000000-00000","journal-title":"Drugs"},{"key":"12884_CR76","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1093\/ajhp\/zxac256","volume":"79","author":"AJ Sucher","year":"2022","unstructured":"Sucher AJ, Thai A, Tran C, Mantena N, Noronha A, Chahine EB (2022) Ibrexafungerp: a new triterpenoid antifungal. Am J Health-Syst Pharm 79:2208\u20132221. https:\/\/doi.org\/10.1093\/ajhp\/zxac256","journal-title":"Am J Health-Syst Pharm"},{"key":"12884_CR77","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1128\/EC.3.4.932-943.2004","volume":"3","author":"A Sussman","year":"2004","unstructured":"Sussman A, Huss K, Chio L-C, Heidler S, Shaw M, Ma D, Zhu G, Campbell RM, Park T-S, Kulanthaivel P, Scott JE, Carpenter JW, Strege MA, Belvo MD, Swartling JR, Fischl A, Yeh W-K, Shih C, Ye XS (2004) Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening. Eukaryot cell 3:932\u2013943. https:\/\/doi.org\/10.1128\/EC.3.4.932-943.2004","journal-title":"Eukaryot cell"},{"key":"12884_CR78","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40265-023-01891-8","volume":"83","author":"YY Syed","year":"2023","unstructured":"Syed YY (2023) Rezafungin: first approval. Drugs 83:833\u2013840. https:\/\/doi.org\/10.1007\/s40265-023-01891-8","journal-title":"Drugs"},{"key":"12884_CR79","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1101\/gad.1956410","volume":"24","author":"H Takai","year":"2010","unstructured":"Takai H, Xie Y, de Lange T, Pavletich NP (2010) Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. Genes Dev 24:2019\u20132030. https:\/\/doi.org\/10.1101\/gad.1956410","journal-title":"Genes Dev"},{"key":"12884_CR80","doi-asserted-by":"publisher","first-page":"e00053","DOI":"10.1128\/MMBR.00053-16","volume":"81","author":"A Thammahong","year":"2017","unstructured":"Thammahong A, Puttikamonkul S, Perfect JR, Brennan RG, Cramer RA (2017) Central role of the trehalose biosynthesis pathway in the pathogenesis of human fungal infections: opportunities and challenges for therapeutic development. Microbiol Mol Biol Rev MMBR 81:e00053\u2013e00016. https:\/\/doi.org\/10.1128\/MMBR.00053-16","journal-title":"Microbiol Mol Biol Rev MMBR"},{"key":"12884_CR81","doi-asserted-by":"publisher","unstructured":"Tonziello G, Caraffa E, Pinchera B, Granata G, Petrosillo N (2019) Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases. Infect Dis Rep 11. https:\/\/doi.org\/10.4081\/idr.2019.8208","DOI":"10.4081\/idr.2019.8208"},{"key":"12884_CR82","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.01397-07","volume":"52","author":"P Uppuluri","year":"2008","unstructured":"Uppuluri P, Nett J, Heitman J, Andes D (2008) Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52:1127\u20131132. https:\/\/doi.org\/10.1128\/AAC.01397-07","journal-title":"Antimicrob Agents Chemother"},{"key":"12884_CR83","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1039\/D2RA07217C","volume":"13","author":"T Vanzolini","year":"2023","unstructured":"Vanzolini T, Mambro TD, Magnani M, Menotta M (2023) AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability. RSC Adv 13:6130\u20136142. https:\/\/doi.org\/10.1039\/D2RA07217C","journal-title":"RSC Adv"},{"key":"12884_CR84","doi-asserted-by":"publisher","first-page":"13753","DOI":"10.1021\/acs.jmedchem.2c00902","volume":"65","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xu F, Nichols CB, Shi Y, Hellinga HW, Alspaugh JA, Distefano MD, Beese LS (2022) Structure-guided discovery of potent antifungals that prevent Ras signaling by inhibiting protein farnesyltransferase. J Med Chem 65:13753\u201313770. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00902","journal-title":"J Med Chem"},{"key":"12884_CR85","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/jof8040351","volume":"8","author":"H Ward","year":"2022","unstructured":"Ward H, Parkes N, Smith C, Kluzek S, Pearson R (2022) Consensus for the treatment of tinea pedis: a systematic review of randomised controlled trials. J Fungi 8:351. https:\/\/doi.org\/10.3390\/jof8040351","journal-title":"J Fungi"},{"key":"12884_CR86","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41467-018-08248-w","volume":"10","author":"L Whitesell","year":"2019","unstructured":"Whitesell L, Robbins N, Huang DS, McLellan CA, Shekhar-Guturja T, LeBlanc EV, Nation CS, Hui R, Hutchinson A, Collins C, Chatterjee S, Trilles R, Xie JL, Krysan DJ, Lindquist S, Porco JA, Tatu U, Brown LE, Pizarro J, Cowen LE (2019) Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus. Nat Commun 10:402. https:\/\/doi.org\/10.1038\/s41467-018-08248-w","journal-title":"Nat Commun"},{"key":"12884_CR87","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1038\/s41467-018-07556-5","volume":"9","author":"BL Wickes","year":"2018","unstructured":"Wickes BL, Wiederhold NP (2018) Molecular diagnostics in medical mycology. Nat Commun 9:5135. https:\/\/doi.org\/10.1038\/s41467-018-07556-5","journal-title":"Nat Commun"},{"key":"12884_CR88","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41421-022-00495-y","volume":"8","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhang M, Yang Y, Ding X, Yang P, Huang K, Hu X, Zhang M, Liu X, Yu H (2022) Structures and mechanism of chitin synthase and its inhibition by antifungal drug Nikkomycin Z. Cell Discov 8:129. https:\/\/doi.org\/10.1038\/s41421-022-00495-y","journal-title":"Cell Discov"},{"key":"12884_CR89","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm.2175","volume":"16","author":"H Wurtele","year":"2010","unstructured":"Wurtele H, Tsao S, L\u00e9pine G, Mullick A, Tremblay J, Drogaris P, Lee E-H, Thibault P, Verreault A, Raymond M (2010) Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med 16:774\u2013780. https:\/\/doi.org\/10.1038\/nm.2175","journal-title":"Nat Med"},{"key":"12884_CR90","doi-asserted-by":"publisher","first-page":"935322","DOI":"10.3389\/fcimb.2022.935322","volume":"12","author":"Y Xie","year":"2022","unstructured":"Xie Y, Hua H, Zhou P (2022) Magnolol as a potent antifungal agent inhibits Candida albicans virulence factors via the PKC and Cek1 MAPK signaling pathways. Front Cell Infect Microbiol 12:935322. https:\/\/doi.org\/10.3389\/fcimb.2022.935322","journal-title":"Front Cell Infect Microbiol"},{"key":"12884_CR91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/20477724.2018.1442764","volume":"112","author":"U Yadav","year":"2018","unstructured":"Yadav U, Khan MA (2018) Targeting the GPI biosynthetic pathway. Pathog Glob Health 112:115\u2013122. https:\/\/doi.org\/10.1080\/20477724.2018.1442764","journal-title":"Pathog Glob Health"},{"key":"12884_CR92","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1248\/bpb.b20-00246","volume":"44","author":"X Yang","year":"2021","unstructured":"Yang X, Pei Z, Hu R, Zhang Z, Lou Z, Sun X (2021) Study on the inhibitory activity and possible mechanism of myriocin on clinically relevant drug-resistant Candida albicans and its biofilms. Biol Pharm Bull 44:305\u2013315. https:\/\/doi.org\/10.1248\/bpb.b20-00246","journal-title":"Biol Pharm Bull"},{"key":"12884_CR93","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/jof9080846","volume":"9","author":"X Yang","year":"2023","unstructured":"Yang X, Shu Y, Cao S, Sun H, Zhang X, Zhang A, Li Y, Ma D, Chen H, Li W (2023) Trehalase inhibitor validamycin may have additional mechanisms of toxicology against Rhizoctonia cerealis. J Fungi 9:846. https:\/\/doi.org\/10.3390\/jof9080846","journal-title":"J Fungi"},{"key":"12884_CR94","doi-asserted-by":"publisher","first-page":"680382","DOI":"10.3389\/fmicb.2021.680382","volume":"12","author":"R Yuan","year":"2021","unstructured":"Yuan R, Tu J, Sheng C, Chen X, Liu N (2021) Effects of Hsp90 inhibitor ganetespib on inhibition of azole-resistant Candida albicans. Front Microbiol 12:680382. https:\/\/doi.org\/10.3389\/fmicb.2021.680382","journal-title":"Front Microbiol"},{"key":"12884_CR95","doi-asserted-by":"publisher","unstructured":"Zhang Q, Liu F, Zeng M, Mao Y, Song Z (2021a) Drug repurposing strategies in the development of potential antifungal agents. Appl Microbiol Biotechnol 1\u201321. https:\/\/doi.org\/10.1007\/s00253-021-11407-7","DOI":"10.1007\/s00253-021-11407-7"},{"key":"12884_CR96","doi-asserted-by":"publisher","first-page":"e0178420","DOI":"10.1128\/JCM.01784-20","volume":"59","author":"SX Zhang","year":"2021","unstructured":"Zhang SX, Babady NE, Hanson KE, Harrington AT, PMK L, Leal SM, Luethy PM, Martin IW, Pancholi P, Procop GW, Riedel S, Seyedmousavi S, Sullivan KV, Walsh TJ, Lockhart SR, Fungal Diagnostics Laboratories Consortium (FDLC) (2021b) Recognition of diagnostic gaps for laboratory diagnosis of fungal diseases: expert opinion from the Fungal Diagnostics Laboratories Consortium (FDLC). J Clin Microbiol 59:e0178420. https:\/\/doi.org\/10.1128\/JCM.01784-20","journal-title":"J Clin Microbiol"},{"key":"12884_CR97","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.2147\/DDDT.S185833","volume":"12","author":"Y-H Zheng","year":"2018","unstructured":"Zheng Y-H, Ma Y-Y, Ding Y, Chen X-Q, Gao G-X (2018) An insight into new strategies to combat antifungal drug resistance. Drug Des Devel Ther 12:3807\u20133816. https:\/\/doi.org\/10.2147\/DDDT.S185833","journal-title":"Drug Des Devel Ther"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12884-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-023-12884-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12884-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:41:50Z","timestamp":1748378510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-023-12884-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["12884"],"URL":"https:\/\/doi.org\/10.1007\/s00253-023-12884-8","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Diatheva s.r.l. supported some studies cited in the text. M.M. holds shares in Diatheva s.r.l. This does not alter our adherence to the Journal policies. T.V. declares that she has no financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}